FDA
The longtime player in the home ECG space may be shoring up to compete with the likes of Apple.
Also: Blockchain for clinical trials; Peloton's upcoming IPO.
The Fenom Pro Asthma Monitor will let clinicians measure the fraction of exhaled nitric oxide in their patient's breath.
The d-Nav Insulin Guidance Service was also the focus of a multi-center, randomized control trial published last week in the Lancet.
The third issue of the global eBook was launched at HIMSS19.
A chat with Apple VP of Health Dr. Sumbul Desai.
The Tandem Diabetes Care t:Slim X2 can work in tandem with other blood sugar management devices, or on its own.
Released yesterday, the document outlines FDA's preference toward single applications for combination products.
The new technology will be integrated into the connected MightSat Rx finger pulse oximeter.
The new guidance aims to modernize the process and generate more market competition.